Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity
- Author(s)
- Ng Liet Hing, M; Ryland, GL; Nguyen, T; Tiong, IS; Dun, K; Ninkovic, S; Nedumannil, R; Westerman, DA; Blombery, PA; Chan, KL; Bajel, A;
- Details
- Publication Year 2023-08,Volume 202,Issue #4,Page 893-896
- Journal Title
- British Journal of Haematology
- Publication Type
- Case report
- Publisher
- Wiley
- Keywords
- Humans; Arsenic Trioxide/therapeutic use; *Leukemia, Promyelocytic, Acute/drug therapy/genetics; Tretinoin/pharmacology/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Oxides/pharmacology/therapeutic use; Oncogene Proteins, Fusion/genetics; *Arsenicals/therapeutic use; Retinoic Acid Receptor alpha; Repressor Proteins
- Department(s)
- Clinical Haematology; Pathology
- PubMed ID
- 37280781
- Publisher's Version
- https://doi.org/10.1111/bjh.18907
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-11-08 07:27:52
Last Modified: 2024-07-16 04:00:46